Literature DB >> 12404221

Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease.

Thomas Marth1, Nicole Kleen, Andreas Stallmach, Sabine Ring, Sheriff Aziz, Carsten Schmidt, Warren Strober, Martin Zeitz, Thomas Schneider.   

Abstract

BACKGROUND & AIMS: An impaired monocyte function and impaired interferon (IFN)-gamma production has been suggested as a possible pathogenetic factor in Whipple's disease (WD) and as a cause for the delayed elimination of Tropheryma whipplei in some patients.
METHODS: We studied, in a series of 20 WD patients with various degrees of disease activity, cellular immune functions.
RESULTS: We found an increased in vitro production of interleukin (IL)-4 by peripheral mononuclear blood cells as determined by enzyme-linked immunosorbent assay, but reduced secretion of IFN-gamma and IL-2 as compared with age- and sex-matched controls. In addition, we observed a significantly reduced monocyte IL-12 production in response to various stimuli in WD patients whereas other cytokines were comparable with controls; these immunologic alterations were not significantly different in patients with various disease activities. At the mucosal level, we found decreased CD4 T-cell percentage and a significantly impaired IFN-gamma secretion.
CONCLUSIONS: Our data define a defective cellular immune response in a large series of WD patients and point to an important pathogenetic role of impaired Th1 responses. The decreased monocyte IL-12 levels may result in reduced peripheral and mucosal IFN-gamma production and lead to an increased susceptibility to T. whipplei infection in certain hosts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404221     DOI: 10.1053/gast.2002.36583

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Relationship between previous treatments and onset of symptoms in patients with Whipple's disease.

Authors:  Lucia Trotta; Federico Biagi; Michele Di Stefano; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2012-06-14       Impact factor: 3.397

2.  [New therapeutic approaches to special diseases of the small intestine].

Authors:  M Schumann; K Herrlinger; M Zeitz; E F Stange
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

3.  From past sailors' eras to the present day: scurvy as a surprising manifestation of an uncommon gastrointestinal disease.

Authors:  Diogo Ferreira Branquinho; Miguel Pinto-Gouveia; Sofia Mendes; Carlos Sofia
Journal:  BMJ Case Rep       Date:  2015-09-16

Review 4.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

5.  Whipple's Disease.

Authors:  Klaus Mönkemüller; Lucía C Fry; Steffen Rickes; Peter Malfertheiner
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

Review 6.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

7.  -295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease.

Authors:  F Biagi; A Schiepatti; C Badulli; I Sbarsi; L Trotta; G E Feurle; C Müller; V Moos; T Schneider; T Marth; M De Amici; M Martinetti; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-08       Impact factor: 3.267

Review 8.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.

Authors:  Jamie Ann Elchert; Emad Mansoor; Mohannad Abou-Saleh; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

10.  IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.

Authors:  Eric Ghigo; Abdoulaye Oury Barry; Lionel Pretat; Khatoun Al Moussawi; Benoît Desnues; Christian Capo; Hardy Kornfeld; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.